Form 4: Director Douglas Williams Receives CAMP Stock Options

Director Douglas E. Williams was granted 28,000 stock options in Camp4 Therapeutics Corp.

Summary

• Director Douglas E. Williams received a grant of 28,000 stock options for Camp4 Therapeutics Corp (CAMP).
• The options have an exercise price of $4.34 per share.
• The grant date for these options is June 10, 2026.
• The options are set to expire on June 9, 2036.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a routine administrative filing regarding director compensation, which carries a neutral sentiment.

Positives

• Alignment of director interests with long-term shareholder value through equity-based compensation.

Negatives

• Potential for future dilution of existing shareholders upon the exercise of these options.

Risks

• Vesting is contingent upon continued service to the company.

Future Outlook

The options vest in their entirety on the earlier of the first anniversary of the grant date or the date of the issuer's next annual meeting of stockholders, provided the director remains in service.

Industry Context

StockSavvy.ai notes that equity grants to directors are standard corporate governance practice in the biotechnology sector to ensure board members are incentivized to oversee long-term strategic growth.

Comparison to Industry Standards

• The grant of stock options to non-employee directors is consistent with standard compensation packages for early-to-mid-stage biotech companies.
• The vesting schedule tied to the next annual meeting is a common practice to ensure board continuity.

Stakeholder Impact

• Shareholders may experience minor dilution if these options are exercised in the future.

Next Steps

• Vesting of options on the earlier of June 10, 2027, or the date of the next annual meeting.

Key Dates

Keywords

Camp4 Therapeutics, CAMP, Form 4, Stock Options, Insider Trading, Director Compensation